Lifecore Biomedical Announces Chief Financial Officer Transition
August 29, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Arvinas to Participate in Upcoming Investor Conferences
August 29, 2024 07:00 ET
|
Arvinas Inc.
NEW HAVEN, Conn., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Adagene to Participate in Investor Conferences in September
August 29, 2024 07:00 ET
|
Adagene Inc.
SAN DIEGO and SUZHOU, China, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and...
17 Education & Technology Group Inc. to Report Second Quarter 2024 Unaudited Financial Results on September 4, 2024
August 29, 2024 07:00 ET
|
17 Education & Technology Group Inc.
17 Education & Technology Group Inc. to Report Second Quarter 2024 Unaudited Financial Results
G-III Apparel Group Announces Date for Second Quarter 2025 Results
August 29, 2024 07:00 ET
|
G-III Apparel Group, LTD.
NEW YORK, Aug. 29, 2024 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NASDAQ: GIII) a global fashion leader with expertise in design, sourcing, and manufacturing, today announced that it will...
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
August 29, 2024 07:00 ET
|
Apellis Pharmaceuticals, Inc.
WALTHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq: APLS) today announced that the company will participate in the following September investor conferences: ...
Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)
August 29, 2024 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Investigator-initiated Phase 2 trial to evaluate TNX-102 SL’s potential to reduce severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD) and posttraumatic stress disorder...
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
August 29, 2024 07:00 ET
|
Rapport Therapeutics, Inc.
BOSTON and SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational...
TScan Therapeutics to Participate in Upcoming Investor Conferences
August 29, 2024 07:00 ET
|
TScan Therapeutics, Inc.
WALTHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T...
Alector to Participate in Upcoming Healthcare Conferences
August 29, 2024 07:00 ET
|
Alector, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will...